Law firm Wright & Schulte said they filed a legal complaint on behalf of patients, pointing to the health system’s alleged lack of transparency and negligence in protecting data as the basis for the lawsuit.

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

On Monday a district judge in Massachusetts declared the Trump administration’s squashing of billions in NIH grants “void and illegal.” 

Researchers at Cybernews said they discovered a database online containing patient names, contact information and appointment records from millions of patients who received dental care. No one has claimed the database. However, clues point to it belonging to Gargle, an industry marketing group. 

Some infusion systems manufactured by Zyno Medical were released with unapproved software that could cause safety features to malfunction. Use of any device subject to the recall is to cease immediately. 

“Just as medicine has its own language, so does business," two surgeons explained in a new editorial. 

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

An exclusive interview with Hal Andrews, President and CEO of Trilliant Health, on the topic of price transparency and how regulators and companies can contain costs for patients.